BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
晚期皮肤 T 细胞淋巴瘤中的 BET 抑制与 BCL2 抑制或 HDAC 抑制具有协同增强作用
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.25670
Sa Rang Kim, Julia M Lewis, Benoit M Cyrenne, Patrick F Monico, Fatima N Mirza, Kacie R Carlson, Francine M Foss, Michael Girardi
